TABLE 4:
Sensitivity and Specificities of Selected Stains and Combination of Stains
Sensitivity % | Specificity % | Area under Curve* | Confidence Interval (95%) | |
---|---|---|---|---|
S100 (−) | 58 | 100 | 0.757 | 0.639-0.875 |
SOX10 (−) | 75 | 100 | 0.878 | 0.790-0.967 |
Neurofibromin (−) | 68 | 100 | 0.838 | 0.738-0.938 |
p16 (−) | 73 | 100 | 0.919 | 0.846-0.992 |
EGFR (+) | 69 | 100 | 0.878 | 0.790-0.967 |
p75NTR (+) | 80 | 69 | 0.765 | 0.639-0.892 |
EGFR (+) or Neurofibromin (−) | 84 | 100 | 0.919 | 0.846-0.992 |
EGFR (+) or p16 (−) | 89 | 100 | 0.946 | 0.885-1.006 |
p16 (−) or Neurofibromin (−) | 89 | 100 | 0.946 | 0.885-1.006 |
EGFR (+) or p16 (−) or Neurofibromin (−) | 92 | 100 | 0.959 | 0.907-1.012 |
Ki67>20% | 87 | 96 | 0.914^ | 0.840-0.988 |
(−): Diffuse loss, expression in less than 5% of tumor cells; (+): positive, expression in 5% or more of the tumor cells;
Continues variables (percentage of positive cells) were used to create receiver operating characteristics curve and 20% was chosen as cut-off.